Anti-PLA2R autoantibodies induce complement activation via IgG subclass-dependent epitope pairings in membranous nephropathy. [PDF]
Wu TY +19 more
europepmc +1 more source
Rituximab Outcomes and Predictors of Treatment Failure in Primary Membranous Nephropathy: A Retrospective Cohort Study. [PDF]
Güllülü Boz SE +9 more
europepmc +1 more source
Risk prediction of PLA2R-Ab-negative membranous nephropathy: an interpretable multicenter machine learning model. [PDF]
Qian K +9 more
europepmc +1 more source
Comparison of efficacy and safety among four therapeutic regimens in primary membranous nephropathy with high anti-PLA2R antibody titers: a single-center retrospective cohort study. [PDF]
Huang Y +7 more
europepmc +1 more source
An unusual presentation of membranous nephropathy with primary and secondary features: a case report. [PDF]
Shah A, Baker S, Shah DB.
europepmc +1 more source
Diagnostic performance and inter-observer reproducibility of glomerular PLA2R immunohistochemistry in primary membranous nephropathy: a multi-laboratory blinded observer study. [PDF]
Tougaard BG +7 more
europepmc +1 more source
Belimumab With Rituximab for the Treatment of Primary Membranous Nephropathy. [PDF]
Chung SA +17 more
europepmc +1 more source
Predicting membranous nephropathy remission: a nomogram based on early dynamic biomarkers. [PDF]
Wang C, Hu C, Zhang M, Li R.
europepmc +1 more source
Contemporary review of primary membranous nephropathy. [PDF]
Filippone EJ, Farber JL.
europepmc +1 more source

